Pulmonx (LUNG) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to -$76.5 million.
- Pulmonx's Enterprise Value rose 2897.6% to -$76.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.5 million, marking a year-over-year increase of 2897.6%. This contributed to the annual value of -$101.5 million for FY2024, which is 1333.88% up from last year.
- Latest data reveals that Pulmonx reported Enterprise Value of -$76.5 million as of Q3 2025, which was up 2897.6% from -$84.2 million recorded in Q2 2025.
- Pulmonx's Enterprise Value's 5-year high stood at -$76.5 million during Q3 2025, with a 5-year trough of -$219.1 million in Q1 2021.
- Moreover, its 5-year median value for Enterprise Value was -$135.2 million (2023), whereas its average is -$139.5 million.
- In the last 5 years, Pulmonx's Enterprise Value crashed by 124885.17% in 2021 and then skyrocketed by 2897.6% in 2025.
- Over the past 5 years, Pulmonx's Enterprise Value (Quarter) stood at -$180.0 million in 2021, then grew by 21.61% to -$141.1 million in 2022, then increased by 17.03% to -$117.1 million in 2023, then grew by 13.34% to -$101.5 million in 2024, then rose by 24.57% to -$76.5 million in 2025.
- Its Enterprise Value stands at -$76.5 million for Q3 2025, versus -$84.2 million for Q2 2025 and -$88.7 million for Q1 2025.